The fitness cost of rifampicin resistance in Pseudomonas aeruginosa depends on demand for RNA polymerase

Genetics

Volumn 187, Issue 3, 2011, Pages 817-822

  Hall, Alex R ^a   Iles, James C ^a   MacLean, R Craig ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBENICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); PENICILLIN BINDING PROTEIN; RIFAMPICIN; RNA POLYMERASE; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; CARBON SOURCE; DRUG PROTEIN BINDING; ENZYME ACTIVITY; GROWTH RATE; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; DNA GYRASE; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; GENETIC FITNESS; MUTATION; PENICILLIN-BINDING PROTEINS; PSEUDOMONAS AERUGINOSA; RIFAMPIN;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 79953197586     PISSN: 00166731     EISSN: 00166731     Source Type: Journal    
DOI: 10.1534/genetics.110.124628     Document Type: Article

References (35)

1. ANDERSSON, D. I., 2003 Persistence of antibiotic resistant bacteria. Curr. Opin, Microbiol. 6: 452-456.
2. ANDERSSON, D. I., 2006 The biological cost of mutational antibiotic resistance: Any practical conclusions? Curr. Opin. Microbiol. 9: 461-465.
3. ANDERSSON, D. I., and D. HUGHES, 2010 Antibiotic resistance and its cost: Is it possible to reverse resistance? Nat. Rev. Microbiol. 8: 260-271.
4. BJÖRKMAN, J., I. NAGAEV, O. G. BERG, D. HUGHES and D. I. ANDERSSON, 2000 Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287: 1479-1482.
5. BLANC-POTARD, A. B., E. GARI, F. SPIRITO, N. FIGUEROA-BOSSI and L. BOSSI, 1995 RNA polymerase (rpob) mutants selected for increased resistance to gyrase inhibitors in Salmonella typhimurium. Mol. Gen. Genet. 247: 680-692.
6. CAMPBELL, E. A., N. KORZHEVA, A. MUSTAEV, K. MURAKAMI, S. NAIR et al., 2001 Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104: 901-912.
7. JASNOS, L., K. TOMALA, D. PACZESNIAK and R. KORONA, 2008 Interactions between stressful environment and gene deletions alleviate the expected average loss of fitness in yeast. Genetics 178: 2105-2111.
8. JIN, D. J., and C. A. GROSS, 1989 Characterization of the pleiotropic phenotypes of rifampin-resistant rpob mutants of Escherichia coli. J. Bacteriol. 171: 5229-5231.
9. KISHONY, R., and S. LEIBLER, 2003 Environmental stresses can alleviate the average deleterious effect of mutations. J. Biol. 2: 14.
10. KLIPP, E., W. LIEBERMEISTER, C. WIERLING, A. KOWALD, H. LEHRACH et al., 2009 Systems Biology. Wiley-VCH, Weinheim, Germany.
11. KORONA, R., 1999 Genetic load of the yeast Saccharomyces cerevisiae under diverse environmental conditions. Evolution 53: 1966-1971.
12. MACLEAN, R. C., 2010 Predicting epistasis: an experimental test of metabolic control theory with bacterial transcription and translation. J. Evol. Biol. 23: 488-493.
13. MACLEAN, R. C., and G. BELL, 2002 Experimental adaptive radiation in Pseudomonas. Am. Nat. 160: 569-581.
14. MACLEAN, R. C., and A. BUCKLING, 2009 The distribution of fitness effects of beneficial mutations in Pseudomonas aeruginosa. PLoS Genet. 5: e1000406.
15. MACLEAN, R. C., G. G. PERRON and A. GARDNER, 2010 Diminishing returns from beneficial mutations and pervasive epistasis shape the fitness landscape for rifampicin resistance in Pseudomonas aeruginosa. Genetics 186: 1345-1354.
16. MAISNIER-PATIN, S., and D. I. ANDERSSON, 2004 Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res. Microbiol. 155: 360-369.
17. MILLER,M. B., and B. L. BASSLER, 2001 Quorum sensing in bacteria. Annu. Rev. Microbiol. 55: 165-199.
18. NAGAEV, I., J. BJÖRKMAN, D. I. ANDERSSON and D. HUGHES, 2001 Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol. Microbiol. 40: 433-439.
19. PAULANDER, W., S. MAISNIER-PATIN and D. I. ANDERSSON, 2009 The fitness cost of streptomycin resistance depends on rpsL mutation, carbon source and RpoS (ss). Genetics 183: 539-546.
20. PERKINS, A. E., and W. L. NICHOLSON, 2008 Uncovering new metabolic capabilities of Bacillus subtilis using phenotype profiling of rifampin-resistant rpoB mutants. J. Bacteriol. 190: 807-814.
21. PETERSEN, A., F. M. AARESTRUP and J. E. OLSEN, 2009 The in vitro fitness cost of antimicrobial resistance in Escherichia coli varies with the growth conditions. FEMS Microbiol. Lett. 299: 53-59.
22. POZZI, G., M. MELONI, E. IONA, G. ORRU, O. F. THORESEN et al., 1999 rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy. J. Clin. Microbiol. 37: 1197-1199.
23. PROSHKIN, S., A. R. RAHMOUNI, A. MIRONOV and E. NUDLER, 2010 Cooperation between translating ribosomes and RNA polymerase in transcription elongation. Science 328: 504-508.
24. REYNOLDS, M. G., 2000 Compensatory evolution in rifampin-resistant Escherichia coli. Genetics 156: 1471-1481.
25. RUUSALA, T., D. ANDERSSON, M. EHRENBERG and C. G. KURLAND, 1984 Hyper-accurate ribosomes inhibit growth. EMBO J. 3: 2575-2580.
26. RYU, J. I., 1978 Pleiotropic effect of a rifampin-resistant mutation in Bacillus subtilis. J. Bacteriol. 135: 408-414.
27. SEVERINOV, K., M. SOUSHKO, A. GOLDFARB and V. NIKIFOROV, 1993 Rifampicin region revisited: new rifampicin-resistant and streptolydigin-resistant mutants in the β-subunit of Escherichia coli RNA polymerase. J. Biol. Chem. 268: 14820-14825.
28. SHABALINA, S. A., L. Y. YAMPOLSKY andA. S. KONDRASHOV, 1997 Rapid decline of fitness in panmictic populations of Drosophila melanogaster maintained under relaxed natural selection. Proc. Natl. Acad. Sci. USA 94: 13034-13039.
29. SZAFRANIEC, K., R. H. BORTS and R. KORONA, 2001 Environmental stress and mutational load in diploid strains of the yeast Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 98: 1107-1112.
30. SZATHMÁRY, E., 1993 Do deleterious mutations act synergistically: metabolic control theory provides a partial answer. Genetics 133: 127-132.
31. TELENTI, A., P. IMBODEN, F. MARCHESI, D. LOWRIE, S. COLE et al., 1993 Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341: 647-650.
32. TRINDADE, S., A. SOUSA, K. B. XAVIER, F. DIONISIO, M. G. FERREIRA et al., 2009 Positive epistasis drives the acquisition of multidrug resistance. PLoS Genet. 5: e1000578.
33. TRINH, V., M. F. LANGELIER, J. ARCHAMBAULT and B. COULOMBE, 2006 Structural perspective on mutations affecting the function of multisubunit RNA polymerases. Microbiol. Mol. Biol. Rev. 70: 12-36.
34. WALSH, C., 2000 Molecular mechanisms that confer antibacterial drug resistance. Nature 406: 775-781.
35. WHITELEY, M., K. M. LEE and E. P. GREENBERG, 1999 Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 96: 13904-13909.